 The data that came out of this ZEPP-bound weight loss treatment study was astounding. It reduced sleep apnea by almost 63%, and a large number of the people who were in the trial said that they no longer had sleep apnea. Now, the interesting thing about this is that for ResMed, GLP-1 drugs have actually been around for a while.